NIH-funded research R21 grant

Investigating how diabetes affects urinary tract infections caused by Group B Streptococcus

Official title: Understanding the pathophysiology of GBS UTI in diabetes

Funded at University of Louisiana at Lafayette · NIH-10495253 · Data updated 2026-11-12

This study is looking into why people with diabetes are more likely to get urinary tract infections from a bacteria called Group B Streptococcus, and it aims to find out how diabetes affects the urinary system and the immune response, which could help improve prevention methods for these infections.

More Diabetes research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Louisiana at Lafayette
NIH-funded
Lab location1 site (Lafayette, United States)
Project startSeptember 24, 2021
Project endAugust 31, 2025
Funding year2022
Award (this year)$171,742
NIH project number5R21AI165939-02
Project IDNIH-10495253 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults with diabetes who are at risk for urinary tract infections.

Less likely to help

Patients without diabetes or those who do not experience urinary tract infections may not benefit from this research.

What this research studies

This research focuses on understanding why individuals with diabetes are more prone to urinary tract infections (UTIs) caused by Group B Streptococcus (GBS). It aims to explore how the diabetic urinary environment may enhance the bacteria's ability to cause infections and weaken the body's immune response. Using mouse models of both type 1 and type 2 diabetes, the study will investigate the interactions between GBS and the immune system in the urinary tract. The findings could provide insights into the mechanisms behind these infections and lead to better prevention strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for urinary tract infections in diabetic patients.

How similar studies have gone: Previous research has shown success in understanding bacterial infections in diabetic patients, but this specific investigation into GBS-UTI is relatively novel.

Where this research is happening

  • University of Louisiana at Lafayette
    Lafayette, United States
    Active

Researchers

  • Principal investigator: Kulkarni, Ritwij — University of Louisiana at Lafayette
  • Study coordinator: Kulkarni, Ritwij

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.